SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-005949
Filing Date
2022-01-20
Accepted
2022-01-20 16:30:51
Documents
14
Period of Report
2022-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm223143-1_8k.htm   iXBRL 8-K 32091
2 EXHIBIT 10.1 tm223143d1_ex10-1.htm EX-10.1 29931
3 EXHIBIT 10.2 tm223143d1_ex10-2.htm EX-10.2 21057
  Complete submission text file 0001104659-22-005949.txt   269960

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ctso-20220119.xsd EX-101.SCH 3045
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctso-20220119_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctso-20220119_pre.xml EX-101.PRE 22603
8 EXTRACTED XBRL INSTANCE DOCUMENT tm223143-1_8k_htm.xml XML 3602
Mailing Address 7 DEER PARK DRIVE, SUITE K MONMOUTH JUNCTION NJ 08852
Business Address 7 DEER PARK DRIVE, SUITE K MONMOUTH JUNCTION NJ 08852 973-329-8885
Cytosorbents Corp (Filer) CIK: 0001175151 (see all company filings)

IRS No.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36792 | Film No.: 22542646
SIC: 3841 Surgical & Medical Instruments & Apparatus